Published in J Am Coll Cardiol on November 28, 2006
Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop. Circulation (2010) 2.94
Verapamil-sensitive left anterior fascicular ventricular tachycardia associated with a healed myocardial infarction: changes in the delayed Purkinje potential during sinus rhythm. J Interv Card Electrophysiol (2008) 1.46
Purkinje cells from RyR2 mutant mice are highly arrhythmogenic but responsive to targeted therapy. Circ Res (2010) 1.41
Contactin-2 expression in the cardiac Purkinje fiber network. Circ Arrhythm Electrophysiol (2010) 1.33
Electrophysiological challenges of cell-based myocardial repair. Circulation (2009) 1.30
Unique cardiac Purkinje fiber transient outward current β-subunit composition: a potential molecular link to idiopathic ventricular fibrillation. Circ Res (2013) 1.00
Coupled personalization of cardiac electrophysiology models for prediction of ischaemic ventricular tachycardia. Interface Focus (2011) 0.93
Narrow QRS ventricular tachycardia from the posterior mitral annulus without involvement of the His-Purkinje system in a patient with prior inferior myocardial infarction. Heart Vessels (2010) 0.83
Complex and rate-dependent beat-to-beat variations in Ca2+ transients of canine Purkinje cells. J Mol Cell Cardiol (2011) 0.83
The infrahisian conduction system and endocavitary cardiac structures: relevance for the invasive electrophysiologist. J Interv Card Electrophysiol (2013) 0.82
Catheter Ablation of Ventricular Arrhythmias via the Radial Artery in a Patient With Prior Myocardial Infarction and Peripheral Vascular Disease. Korean Circ J (2012) 0.82
Optogenetic determination of the myocardial requirements for extrasystoles by cell type-specific targeting of ChannelRhodopsin-2. Proc Natl Acad Sci U S A (2015) 0.80
Isolation and characterization of embryonic stem cell-derived cardiac Purkinje cells. Stem Cells (2015) 0.79
Purkinje fibers and arrhythmias. Pacing Clin Electrophysiol (2009) 0.79
Role of catheter ablation of ventricular tachycardia associated with structural heart disease. World J Cardiol (2011) 0.78
Electrophysiologic and histopathologic findings of the ablation sites for ventricular fibrillation in a patient with ischemic cardiomyopathy. J Interv Card Electrophysiol (2008) 0.77
A review of the literature on cardiac electrical activity between fibroblasts and myocytes. Prog Biophys Mol Biol (2015) 0.77
Septal involvement in patients with post-infarction ventricular tachycardia: implications for mapping and radiofrequency ablation. J Am Coll Cardiol (2011) 0.76
VT ablation in heart failure. Herzschrittmacherther Elektrophysiol (2012) 0.76
Hemodynamic effects of Purkinje potential pacing in the left ventricular endocardium in patients with advanced heart failure. J Arrhythm (2015) 0.75
Ischemic ventricular tachycardia presenting as a narrow complex tachycardia. Indian Pacing Electrophysiol J (2014) 0.75
Delayed Purkinje potentials during sinus rhythm in post MI patients-an underrecognized target for VT ablation? J Interv Card Electrophysiol (2008) 0.75
His bundle activates faster than ventricular myocardium during prolonged ventricular fibrillation. PLoS One (2014) 0.75
Ventricular arrhythmias and the His-Purkinje system. Nat Rev Cardiol (2016) 0.75
Phenotypically silent Cre recombination within the postnatal ventricular conduction system. PLoS One (2017) 0.75
Verapamil-sensitive left posterior fascicular ventricular tachycardia after myocardial infarction. J Interv Card Electrophysiol (2008) 0.75
Findings on magnetic resonance imaging of fascicular ventricular tachycardia. J Interv Card Electrophysiol (2013) 0.75
Malignant idiopathic ventricular fibrillation "cured" by radiofrequency ablation. J Interv Card Electrophysiol (2008) 0.75
[Electrical storm in the emergency room: clinical pathways]. Herzschrittmacherther Elektrophysiol (2014) 0.75
Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N Engl J Med (2006) 7.40
Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med (2007) 5.05
Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol (2002) 4.60
Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation versus left atrial ablation. Circulation (2003) 3.99
Atrio-esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation. Circulation (2004) 3.69
Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation (2002) 3.32
Pulmonary vein isolation by duty-cycled bipolar and unipolar radiofrequency energy with a multielectrode ablation catheter. Heart Rhythm (2008) 3.19
Radiofrequency catheter ablation of chronic atrial fibrillation guided by complex electrograms. Circulation (2007) 2.87
Relationship between burden of premature ventricular complexes and left ventricular function. Heart Rhythm (2010) 2.76
Radiofrequency ablation of frequent, idiopathic premature ventricular complexes: comparison with a control group without intervention. Heart Rhythm (2007) 2.65
Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: report from a multicenter registry. Heart Rhythm (2008) 2.40
Movement of the esophagus during left atrial catheter ablation for atrial fibrillation. J Am Coll Cardiol (2005) 2.34
A randomized assessment of the incremental role of ablation of complex fractionated atrial electrograms after antral pulmonary vein isolation for long-lasting persistent atrial fibrillation. J Am Coll Cardiol (2009) 2.29
Atrial tachycardia after circumferential pulmonary vein ablation of atrial fibrillation: mechanistic insights, results of catheter ablation, and risk factors for recurrence. J Am Coll Cardiol (2007) 2.29
Anatomy of the pulmonary veins in patients with atrial fibrillation and effects of segmental ostial ablation analyzed by computed tomography. J Cardiovasc Electrophysiol (2003) 2.22
Relationship between the spectral characteristics of atrial fibrillation and atrial tachycardias that occur after catheter ablation of atrial fibrillation. Heart Rhythm (2008) 2.20
Feasibility of postmortem device acquisition for potential reuse in underserved nations. Heart Rhythm (2011) 2.14
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. J Interv Card Electrophysiol (2012) 2.08
Electrosurgery and implantable electronic devices: review and implications for office-based procedures. Dermatol Surg (2011) 2.07
Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia--AMIOVIRT. J Am Coll Cardiol (2003) 2.05
Ventricular arrhythmias originating from a papillary muscle in patients without prior infarction: a comparison with fascicular arrhythmias. Heart Rhythm (2008) 1.98
A tailored approach to catheter ablation of paroxysmal atrial fibrillation. Circulation (2006) 1.98
Delayed-enhanced magnetic resonance imaging in nonischemic cardiomyopathy: utility for identifying the ventricular arrhythmia substrate. J Am Coll Cardiol (2009) 1.96
Reasons for recurrent ventricular tachycardia after catheter ablation of post-infarction ventricular tachycardia. J Am Coll Cardiol (2012) 1.89
Mechanisms of recurrent atrial fibrillation after pulmonary vein isolation by segmental ostial ablation. Heart Rhythm (2004) 1.89